Descriptive analytical study identifies marker changes in acute and chronic coronary conditions, suggesting shared pathways.
Objectives Applying the multi-marker panel in patients with STEMI, NSTEMI and non-obstructive chronic coronary disease (no-CCD) aiming for the estimation of either common or non-common changes of admission levels of 37 markers. Methods The descriptive analytical study was conducted on 3 equal groups of patients (n=80 each) with STEMI, NSTEMI and no-CCD formed on the basis of a longitudinal cohort study comprising 516 patients with STEMI, 627 with NSTEMI and 173 patients with no-CCD. Serum levels of markers were determined by ELISA and cell flow cytometry. Results IL-1ß, soluble receptor of IL-6, TNF-α and hsCRP increased in all 3 groups, excepting normal level of neopterin and IL-10 inherent to no-CCD. Commonly for endothelial dysfunction was elevation of endocan and angiopoietin 2 (Apo2), whilst raising of endothelial microparticles characterized acute coronary syndrome (ACS). Decreased paraoxonase 1, Ang1-7/Ang II ratio and catestatin, as well as increased oxi-HDL, LP(a), Willebrand/ADAMTS13 ratio, neprilysin and growth differentiation factor 15 (GDF-15), are common signs as well. Conclusions Quite many similar changes of markers in patients with ACS and no-CCD suggest a pathogenic interface consisting of common pillars, which conceptually might also predict the coronary microcirculatory dysfunction often occurred in these pathologies.
No takes yet. Share an insight, caveat, or question.
Mihaela Munteanu (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: